This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03411/identifier/pdb/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB03411/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03411/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03411/identifier/drugbank/

Statements

Subject Item
n2:DB03411
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03411 n13:DB03411
dcterms:title
2-Hydroxymethyl-Pyrrolidine-3,4-Diol
adms:identifier
n8:IMR n9:127716 n10:DB03411 n11:46504688
n3:IUPAC-Name
n4:271B458C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4592-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4591-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B458E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B458F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4590-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B458A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4588-363D-11E5-9242-09173F13E4C5 n4:271B458B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4589-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4598-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4599-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4593-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4594-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4596-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4595-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4597-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B459E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B45A0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B45A1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B459D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B459C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B459F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B458D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B459A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B459B-363D-11E5-9242-09173F13E4C5